ABBOTINDIA: Q1 FY25 saw strong revenue and profit growth, with EPS up 13% year-over-year

About this update from Abbott India Limited

Revenue and net profit grew year-over-year in Q1 FY25, with EPS rising to ₹154.36. Financials were reviewed and approved without qualifications, and the company continues to operate solely in the pharmaceuticals segment.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Abbott India Limited